Global Second Generation Cephalosporins Market Research Report 2021

1 Second Generation Cephalosporins Market Overview

• 1.1 Product Overview and Scope of Second Generation Cephalosporins
• 1.2 Second Generation Cephalosporins Segment by Type
  • 1.2.1 Global Second Generation Cephalosporins Sales Growth Rate Comparison by Type (2021-2027)
  • 1.2.2 Cefotiam
  • 1.2.3 Cefuroxime
• 1.3 Second Generation Cephalosporins Segment by Application
  • 1.3.1 Global Second Generation Cephalosporins Sales Comparison by Application: (2021-2027)
  • 1.3.2 Respiratory Tract Infection
  • 1.3.3 Otolaryngological Infection
  • 1.3.4 Urinary Tract Infection
  • 1.3.5 Skin and Soft Tissue Infections
  • 1.3.6 Bone and Joint Infections
  • 1.3.7 Gonorrhea
  • 1.3.8 Other
• 1.4 Global Second Generation Cephalosporins Market Size Estimates and Forecasts
  • 1.4.1 Global Second Generation Cephalosporins Revenue 2016-2027
  • 1.4.2 Global Second Generation Cephalosporins Sales 2016-2027
  • 1.4.3 Second Generation Cephalosporins Market Size by Region: 2016 Versus 2021 Versus 2027

2 Second Generation Cephalosporins Market Competition by Manufacturers

• 2.1 Global Second Generation Cephalosporins Sales Market Share by Manufacturers (2016-2021)
• 2.2 Global Second Generation Cephalosporins Revenue Market Share by Manufacturers (2016-2021)
• 2.3 Global Second Generation Cephalosporins Average Price by Manufacturers (2016-2021)
• 2.4 Manufacturers Second Generation Cephalosporins Manufacturing Sites, Area Served, Product Type
• 2.5 Second Generation Cephalosporins Market Competitive Situation and Trends
  • 2.5.1 Second Generation Cephalosporins Market Concentration Rate
  • 2.5.2 The Global Top 5 and Top 10 Largest Second Generation Cephalosporins Players Market Share by Revenue
  • 2.5.3 Global Second Generation Cephalosporins Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Second Generation Cephalosporins Retrospective Market Scenario by Region

• 3.1 Global Second Generation Cephalosporins Retrospective Market Scenario in Sales by Region: 2016-2021
• 3.2 Global Second Generation Cephalosporins Retrospective Market Scenario in Revenue by Region: 2016-2021
• 3.3 North America Second Generation Cephalosporins Market Facts & Figures by Country
  • 3.3.1 North America Second Generation Cephalosporins Sales by Country
  • 3.3.2 North America Second Generation Cephalosporins Revenue by Country
  • 3.3.3 United States
  • 3.3.4 Canada
• 3.4 Europe Second Generation Cephalosporins Market Facts & Figures by Country
  • 3.4.1 Europe Second Generation Cephalosporins Sales by Country
  • 3.4.2 Europe Second Generation Cephalosporins Revenue by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific Second Generation Cephalosporins Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Second Generation Cephalosporins Sales by Region
  • 3.5.2 Asia Pacific Second Generation Cephalosporins Revenue by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
• 3.6 Latin America Second Generation Cephalosporins Market Facts & Figures by Country
  • 3.6.1 Latin America Second Generation Cephalosporins Sales by Country
  • 3.6.2 Latin America Second Generation Cephalosporins Revenue by Country
  • 3.6.3 Mexico
  • 3.6.4 Brazil
  • 3.6.5 Argentina
  • 3.6.6 Colombia
• 3.7 Middle East and Africa Second Generation Cephalosporins Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Second Generation Cephalosporins Sales by Country
  • 3.7.2 Middle East and Africa Second Generation Cephalosporins Revenue by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 UAE

4 Global Second Generation Cephalosporins Historic Market Analysis by Type

• 4.1 Global Second Generation Cephalosporins Sales Market Share by Type (2016-2021)
• 4.2 Global Second Generation Cephalosporins Revenue Market Share by Type (2016-2021)
• 4.3 Global Second Generation Cephalosporins Price by Type (2016-2021)

5 Global Second Generation Cephalosporins Historic Market Analysis by Application

• 5.1 Global Second Generation Cephalosporins Sales Market Share by Application (2016-2021)
• 5.2 Global Second Generation Cephalosporins Revenue Market Share by Application (2016-2021)
• 5.3 Global Second Generation Cephalosporins Price by Application (2016-2021)

6 Key Companies Profiled

• 6.1 Apotex
  • 6.1.1 Apotex Corporation Information
  • 6.1.2 Apotex Description and Business Overview
  • 6.1.3 Apotex Second Generation Cephalosporins Sales, Revenue and Gross Margin (2016-2021)
  • 6.1.4 Apotex Second Generation Cephalosporins Product Portfolio
  • 6.1.5 Apotex Recent Developments/Updates
• 6.2 Esseti Farmaceutici
  • 6.2.1 Esseti Farmaceutici Corporation Information
  • 6.2.2 Esseti Farmaceutici Description and Business Overview
  • 6.2.3 Esseti Farmaceutici Second Generation Cephalosporins Sales, Revenue and Gross Margin (2016-2021)
  • 6.2.4 Esseti Farmaceutici Second Generation Cephalosporins Product Portfolio
  • 6.2.5 Esseti Farmaceutici Recent Developments/Updates
• 6.3 GSK
  • 6.3.1 GSK Corporation Information
  • 6.3.2 GSK Description and Business Overview
  • 6.3.3 GSK Second Generation Cephalosporins Sales, Revenue and Gross Margin (2016-2021)
  • 6.3.4 GSK Second Generation Cephalosporins Product Portfolio
  • 6.3.5 GSK Recent Developments/Updates
• 6.4 Lilly
  • 6.4.1 Lilly Corporation Information
  • 6.4.2 Lilly Description and Business Overview
  • 6.4.3 Lilly Second Generation Cephalosporins Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Lilly Second Generation Cephalosporins Product Portfolio
  • 6.4.5 Lilly Recent Developments/Updates
• 6.5 Medochemie
  • 6.5.1 Medochemie Corporation Information
  • 6.5.2 Medochemie Description and Business Overview
  • 6.5.3 Medochemie Second Generation Cephalosporins Sales, Revenue and Gross Margin (2016-2021)
  • 6.5.4 Medochemie Second Generation Cephalosporins Product Portfolio
  • 6.5.5 Medochemie Recent Developments/Updates
• 6.6 Northeast Pharmaceutical
  • 6.6.1 Northeast Pharmaceutical Corporation Information
  • 6.6.2 Northeast Pharmaceutical Description and Business Overview
  • 6.6.3 Northeast Pharmaceutical Second Generation Cephalosporins Sales, Revenue and Gross Margin (2016-2021)
  • 6.6.4 Northeast Pharmaceutical Second Generation Cephalosporins Product Portfolio
  • 6.6.5 Northeast Pharmaceutical Recent Developments/Updates
• 6.7 NCPC
  • 6.6.1 NCPC Corporation Information
  • 6.6.2 NCPC Description and Business Overview
  • 6.6.3 NCPC Second Generation Cephalosporins Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 NCPC Second Generation Cephalosporins Product Portfolio
  • 6.7.5 NCPC Recent Developments/Updates
• 6.8 Nanchang Lijian Pharmaceutical
  • 6.8.1 Nanchang Lijian Pharmaceutical Corporation Information
  • 6.8.2 Nanchang Lijian Pharmaceutical Description and Business Overview
  • 6.8.3 Nanchang Lijian Pharmaceutical Second Generation Cephalosporins Sales, Revenue and Gross Margin (2016-2021)
  • 6.8.4 Nanchang Lijian Pharmaceutical Second Generation Cephalosporins Product Portfolio
  • 6.8.5 Nanchang Lijian Pharmaceutical Recent Developments/Updates
• 6.9 Sichuan Pharmaceutical
  • 6.9.1 Sichuan Pharmaceutical Corporation Information
  • 6.9.2 Sichuan Pharmaceutical Description and Business Overview
  • 6.9.3 Sichuan Pharmaceutical Second Generation Cephalosporins Sales, Revenue and Gross Margin (2016-2021)
  • 6.9.4 Sichuan Pharmaceutical Second Generation Cephalosporins Product Portfolio
  • 6.9.5 Sichuan Pharmaceutical Recent Developments/Updates
• 6.10 Shandong Runze Pharmaceutical
  • 6.10.1 Shandong Runze Pharmaceutical Corporation Information
  • 6.10.2 Shandong Runze Pharmaceutical Description and Business Overview
  • 6.10.3 Shandong Runze Pharmaceutical Second Generation Cephalosporins Sales, Revenue and Gross Margin (2016-2021)
  • 6.10.4 Shandong Runze Pharmaceutical Second Generation Cephalosporins Product Portfolio
  • 6.10.5 Shandong Runze Pharmaceutical Recent Developments/Updates
• 6.11 Shandong Luoxin Pharmaceutical Group
  • 6.11.1 Shandong Luoxin Pharmaceutical Group Corporation Information
  • 6.11.2 Shandong Luoxin Pharmaceutical Group Second Generation Cephalosporins Description and Business Overview
  • 6.11.3 Shandong Luoxin Pharmaceutical Group Second Generation Cephalosporins Sales, Revenue and Gross Margin (2016-2021)
  • 6.11.4 Shandong Luoxin Pharmaceutical Group Second Generation Cephalosporins Product Portfolio
  • 6.11.5 Shandong Luoxin Pharmaceutical Group Recent Developments/Updates
• 6.12 Guangdong Bozhou Pharmaceutical
  • 6.12.1 Guangdong Bozhou Pharmaceutical Corporation Information
  • 6.12.2 Guangdong Bozhou Pharmaceutical Second Generation Cephalosporins Description and Business Overview
  • 6.12.3 Guangdong Bozhou Pharmaceutical Second Generation Cephalosporins Sales, Revenue and Gross Margin (2016-2021)
  • 6.12.4 Guangdong Bozhou Pharmaceutical Second Generation Cephalosporins Product Portfolio
  • 6.12.5 Guangdong Bozhou Pharmaceutical Recent Developments/Updates
• 6.13 Guangdong Jincheng Jinsu Pharmaceutical
  • 6.13.1 Guangdong Jincheng Jinsu Pharmaceutical Corporation Information
  • 6.13.2 Guangdong Jincheng Jinsu Pharmaceutical Second Generation Cephalosporins Description and Business Overview
  • 6.13.3 Guangdong Jincheng Jinsu Pharmaceutical Second Generation Cephalosporins Sales, Revenue and Gross Margin (2016-2021)
  • 6.13.4 Guangdong Jincheng Jinsu Pharmaceutical Second Generation Cephalosporins Product Portfolio
  • 6.13.5 Guangdong Jincheng Jinsu Pharmaceutical Recent Developments/Updates
• 6.14 Guangzhou Baiyunshan Tianxin Pharmaceutical
  • 6.14.1 Guangzhou Baiyunshan Tianxin Pharmaceutical Corporation Information
  • 6.14.2 Guangzhou Baiyunshan Tianxin Pharmaceutical Second Generation Cephalosporins Description and Business Overview
  • 6.14.3 Guangzhou Baiyunshan Tianxin Pharmaceutical Second Generation Cephalosporins Sales, Revenue and Gross Margin (2016-2021)
  • 6.14.4 Guangzhou Baiyunshan Tianxin Pharmaceutical Second Generation Cephalosporins Product Portfolio
  • 6.14.5 Guangzhou Baiyunshan Tianxin Pharmaceutical Recent Developments/Updates
• 6.15 Guangxi Kelun Pharmaceutical
  • 6.15.1 Guangxi Kelun Pharmaceutical Corporation Information
  • 6.15.2 Guangxi Kelun Pharmaceutical Second Generation Cephalosporins Description and Business Overview
  • 6.15.3 Guangxi Kelun Pharmaceutical Second Generation Cephalosporins Sales, Revenue and Gross Margin (2016-2021)
  • 6.15.4 Guangxi Kelun Pharmaceutical Second Generation Cephalosporins Product Portfolio
  • 6.15.5 Guangxi Kelun Pharmaceutical Recent Developments/Updates
• 6.16 Yuekang Pharmaceutical Group
  • 6.16.1 Yuekang Pharmaceutical Group Corporation Information
  • 6.16.2 Yuekang Pharmaceutical Group Second Generation Cephalosporins Description and Business Overview
  • 6.16.3 Yuekang Pharmaceutical Group Second Generation Cephalosporins Sales, Revenue and Gross Margin (2016-2021)
  • 6.16.4 Yuekang Pharmaceutical Group Second Generation Cephalosporins Product Portfolio
  • 6.16.5 Yuekang Pharmaceutical Group Recent Developments/Updates
• 6.17 Shantou Jinshi Injection
  • 6.17.1 Shantou Jinshi Injection Corporation Information
  • 6.17.2 Shantou Jinshi Injection Second Generation Cephalosporins Description and Business Overview
  • 6.17.3 Shantou Jinshi Injection Second Generation Cephalosporins Sales, Revenue and Gross Margin (2016-2021)
  • 6.17.4 Shantou Jinshi Injection Second Generation Cephalosporins Product Portfolio
  • 6.17.5 Shantou Jinshi Injection Recent Developments/Updates
• 6.18 Zhejiang Yatai Pharmaceutical
  • 6.18.1 Zhejiang Yatai Pharmaceutical Corporation Information
  • 6.18.2 Zhejiang Yatai Pharmaceutical Second Generation Cephalosporins Description and Business Overview
  • 6.18.3 Zhejiang Yatai Pharmaceutical Second Generation Cephalosporins Sales, Revenue and Gross Margin (2016-2021)
  • 6.18.4 Zhejiang Yatai Pharmaceutical Second Generation Cephalosporins Product Portfolio
  • 6.18.5 Zhejiang Yatai Pharmaceutical Recent Developments/Updates
• 6.19 Shenzhen Xinlitai Pharmaceutical
  • 6.19.1 Shenzhen Xinlitai Pharmaceutical Corporation Information
  • 6.19.2 Shenzhen Xinlitai Pharmaceutical Second Generation Cephalosporins Description and Business Overview
  • 6.19.3 Shenzhen Xinlitai Pharmaceutical Second Generation Cephalosporins Sales, Revenue and Gross Margin (2016-2021)
  • 6.19.4 Shenzhen Xinlitai Pharmaceutical Second Generation Cephalosporins Product Portfolio
  • 6.19.5 Shenzhen Xinlitai Pharmaceutical Recent Developments/Updates
• 6.20 Shenzhen Huarun Jiuxin Pharmaceutical
  • 6.20.1 Shenzhen Huarun Jiuxin Pharmaceutical Corporation Information
  • 6.20.2 Shenzhen Huarun Jiuxin Pharmaceutical Second Generation Cephalosporins Description and Business Overview
  • 6.20.3 Shenzhen Huarun Jiuxin Pharmaceutical Second Generation Cephalosporins Sales, Revenue and Gross Margin (2016-2021)
  • 6.20.4 Shenzhen Huarun Jiuxin Pharmaceutical Second Generation Cephalosporins Product Portfolio
  • 6.20.5 Shenzhen Huarun Jiuxin Pharmaceutical Recent Developments/Updates
• 6.21 Zhuhai Union Pharmaceutical
  • 6.21.1 Zhuhai Union Pharmaceutical Corporation Information
  • 6.21.2 Zhuhai Union Pharmaceutical Second Generation Cephalosporins Description and Business Overview
  • 6.21.3 Zhuhai Union Pharmaceutical Second Generation Cephalosporins Sales, Revenue and Gross Margin (2016-2021)
  • 6.21.4 Zhuhai Union Pharmaceutical Second Generation Cephalosporins Product Portfolio
  • 6.21.5 Zhuhai Union Pharmaceutical Recent Developments/Updates
• 6.22 Ruiyang Pharmaceutical
  • 6.22.1 Ruiyang Pharmaceutical Corporation Information
  • 6.22.2 Ruiyang Pharmaceutical Second Generation Cephalosporins Description and Business Overview
  • 6.22.3 Ruiyang Pharmaceutical Second Generation Cephalosporins Sales, Revenue and Gross Margin (2016-2021)
  • 6.22.4 Ruiyang Pharmaceutical Second Generation Cephalosporins Product Portfolio
  • 6.22.5 Ruiyang Pharmaceutical Recent Developments/Updates
• 6.23 Fujian Fukang Pharmaceutical
  • 6.23.1 Fujian Fukang Pharmaceutical Corporation Information
  • 6.23.2 Fujian Fukang Pharmaceutical Second Generation Cephalosporins Description and Business Overview
  • 6.23.3 Fujian Fukang Pharmaceutical Second Generation Cephalosporins Sales, Revenue and Gross Margin (2016-2021)
  • 6.23.4 Fujian Fukang Pharmaceutical Second Generation Cephalosporins Product Portfolio
  • 6.23.5 Fujian Fukang Pharmaceutical Recent Developments/Updates
• 6.24 Suzhou Erye Pharmaceutical
  • 6.24.1 Suzhou Erye Pharmaceutical Corporation Information
  • 6.24.2 Suzhou Erye Pharmaceutical Second Generation Cephalosporins Description and Business Overview
  • 6.24.3 Suzhou Erye Pharmaceutical Second Generation Cephalosporins Sales, Revenue and Gross Margin (2016-2021)
  • 6.24.4 Suzhou Erye Pharmaceutical Second Generation Cephalosporins Product Portfolio
  • 6.24.5 Suzhou Erye Pharmaceutical Recent Developments/Updates
• 6.25 Furen Pharmaceutical Group
  • 6.25.1 Furen Pharmaceutical Group Corporation Information
  • 6.25.2 Furen Pharmaceutical Group Second Generation Cephalosporins Description and Business Overview
  • 6.25.3 Furen Pharmaceutical Group Second Generation Cephalosporins Sales, Revenue and Gross Margin (2016-2021)
  • 6.25.4 Furen Pharmaceutical Group Second Generation Cephalosporins Product Portfolio
  • 6.25.5 Furen Pharmaceutical Group Recent Developments/Updates
• 6.26 Chongqing Kerui Pharmaceutical Group
  • 6.26.1 Chongqing Kerui Pharmaceutical Group Corporation Information
  • 6.26.2 Chongqing Kerui Pharmaceutical Group Second Generation Cephalosporins Description and Business Overview
  • 6.26.3 Chongqing Kerui Pharmaceutical Group Second Generation Cephalosporins Sales, Revenue and Gross Margin (2016-2021)
  • 6.26.4 Chongqing Kerui Pharmaceutical Group Second Generation Cephalosporins Product Portfolio
  • 6.26.5 Chongqing Kerui Pharmaceutical Group Recent Developments/Updates
• 6.27 Shanxi Xidunsi Pharmaceutical
  • 6.27.1 Shanxi Xidunsi Pharmaceutical Corporation Information
  • 6.27.2 Shanxi Xidunsi Pharmaceutical Second Generation Cephalosporins Description and Business Overview
  • 6.27.3 Shanxi Xidunsi Pharmaceutical Second Generation Cephalosporins Sales, Revenue and Gross Margin (2016-2021)
  • 6.27.4 Shanxi Xidunsi Pharmaceutical Second Generation Cephalosporins Product Portfolio
  • 6.27.5 Shanxi Xidunsi Pharmaceutical Recent Developments/Updates
• 6.28 Qilu Pharmaceutical
  • 6.28.1 Qilu Pharmaceutical Corporation Information
  • 6.28.2 Qilu Pharmaceutical Second Generation Cephalosporins Description and Business Overview
  • 6.28.3 Qilu Pharmaceutical Second Generation Cephalosporins Sales, Revenue and Gross Margin (2016-2021)
  • 6.28.4 Qilu Pharmaceutical Second Generation Cephalosporins Product Portfolio
  • 6.28.5 Qilu Pharmaceutical Recent Developments/Updates
• 6.29 Shandong Zibo Xinda Pharmaceutical
  • 6.29.1 Shandong Zibo Xinda Pharmaceutical Corporation Information
  • 6.29.2 Shandong Zibo Xinda Pharmaceutical Second Generation Cephalosporins Description and Business Overview
  • 6.29.3 Shandong Zibo Xinda Pharmaceutical Second Generation Cephalosporins Sales, Revenue and Gross Margin (2016-2021)
  • 6.29.4 Shandong Zibo Xinda Pharmaceutical Second Generation Cephalosporins Product Portfolio
  • 6.29.5 Shandong Zibo Xinda Pharmaceutical Recent Developments/Updates
• 6.30 Guangzhou Nanxin Pharmaceutical
  • 6.30.1 Guangzhou Nanxin Pharmaceutical Corporation Information
  • 6.30.2 Guangzhou Nanxin Pharmaceutical Second Generation Cephalosporins Description and Business Overview
  • 6.30.3 Guangzhou Nanxin Pharmaceutical Second Generation Cephalosporins Sales, Revenue and Gross Margin (2016-2021)
  • 6.30.4 Guangzhou Nanxin Pharmaceutical Second Generation Cephalosporins Product Portfolio
  • 6.30.5 Guangzhou Nanxin Pharmaceutical Recent Developments/Updates

7 Second Generation Cephalosporins Manufacturing Cost Analysis

• 7.1 Second Generation Cephalosporins Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of Second Generation Cephalosporins
• 7.4 Second Generation Cephalosporins Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 Second Generation Cephalosporins Distributors List
• 8.3 Second Generation Cephalosporins Customers

9 Second Generation Cephalosporins Market Dynamics

• 9.1 Second Generation Cephalosporins Industry Trends
• 9.2 Second Generation Cephalosporins Growth Drivers
• 9.3 Second Generation Cephalosporins Market Challenges
• 9.4 Second Generation Cephalosporins Market Restraints

10 Global Market Forecast

• 10.1 Second Generation Cephalosporins Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of Second Generation Cephalosporins by Type (2022-2027)
  • 10.1.2 Global Forecasted Revenue of Second Generation Cephalosporins by Type (2022-2027)
• 10.2 Second Generation Cephalosporins Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Second Generation Cephalosporins by Application (2022-2027)
  • 10.2.2 Global Forecasted Revenue of Second Generation Cephalosporins by Application (2022-2027)
• 10.3 Second Generation Cephalosporins Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Second Generation Cephalosporins by Region (2022-2027)
  • 10.3.2 Global Forecasted Revenue of Second Generation Cephalosporins by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List